Review article · 2025 · Open access
From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery
Drug Discovery Today, 31(1), 104589 · Published 17 December 2025 · DOI 10.1016/j.drudis.2025.104589
In brief
“From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery” is a 2025 review article by Tomasz Szostek and Daniel Szulczyk, published in Drug Discovery Today. OpenAlex counts 12 citations as of 18 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Drug Discovery Today.
- Citations
- 12
- Most cited in
- 2026 (12)
- Field-weighted impact
- 0.50
- References
- 101
- Authors
- 2
Abstract
Activity cliffs (ACs), defined as near structural neighbors with large potency differences, provide high-value information on structure-activity relationship discontinuities that medicinal chemists have leveraged for years. Yet modern artificial intelligence-based discovery frameworks often smooth this signal, yielding confident but unrealistic proposals. We present a three-layer roadmap that treats ACs as a first-class design feature: representation is tuned to expose AC signal during pretraining and sampling; evaluation focuses on steep regions with early recognition, pair-level retrieval, and calibrated uncertainty under fair, series-aware splits; and de novo generation is steered toward the best candidates. Integrated as a closed, self-improving loop, this framework helps practitioners build AC-aware drug design tools.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Szostek, T., & Szulczyk, D. (2025). From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery. Drug Discovery Today, 31(1), 104589. https://doi.org/10.1016/j.drudis.2025.104589
MLA 9
Szostek, Tomasz, and Daniel Szulczyk. “From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery.” Drug Discovery Today, vol. 31, no. 1, 2025, p. 104589. https://doi.org/10.1016/j.drudis.2025.104589.
Chicago
Szostek, Tomasz and Daniel Szulczyk. 2025. “From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery.” Drug Discovery Today 31 (1): 104589. https://doi.org/10.1016/j.drudis.2025.104589.
Harvard
Szostek, T. and Szulczyk, D. (2025) ‘From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery’, Drug Discovery Today, 31(1), p. 104589. doi:10.1016/j.drudis.2025.104589.
IEEE
T. Szostek and D. Szulczyk, “From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery,” Drug Discovery Today, vol. 31, no. 1, p. 104589, 2025, doi: 10.1016/j.drudis.2025.104589.
BibTeX
@article{szostek2025from,
title = {{From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery}},
author = {Szostek, Tomasz and Szulczyk, Daniel},
journal = {Drug Discovery Today},
year = {2025},
volume = {31},
number = {1},
pages = {104589},
doi = {10.1016/j.drudis.2025.104589},
url = {https://doi.org/10.1016/j.drudis.2025.104589}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- activity cliffs
- small molecule drug discovery
- de novo molecule generation
- uncertainty calibration
- structure representation
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Szostek, T., & Szulczyk, D. (2025). From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery. Drug Discovery Today, 31(1), 104589. https://doi.org/10.1016/j.drudis.2025.104589
How many times has this paper been cited?
12 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Drug Discovery Today: sign in and open the full text from this page.
Who wrote this paper?
Tomasz Szostek, Daniel Szulczyk.
What is the DOI of this paper?
10.1016/j.drudis.2025.104589, permanently at https://doi.org/10.1016/j.drudis.2025.104589. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.